We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+44%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$632M
AUM Growth
–
Cap. Flow
+$532M
Cap. Flow %
84.29%
Top 10 Hldgs %
78.2%
Holding
44
New
44
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$66.4M
2
DCP
DCP Midstream, LP
DCP
+$64.6M
3
XRX icon
Xerox
XRX
+$58.5M
4
DRRX
DURECT Corp
DRRX
+$54.6M
5
LIN icon
Linde
LIN
+$38.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 30.38%
2 Energy 20.11%
3 Industrials 17.21%
4 Miscellaneous 12.43%
5 Materials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIBT
26
DELISTED
RiceBran Technologies
RIBT
$2.94M 0.47%
+200,333
New +$4.72M
CUE icon
27
Cue Biopharma
CUE
$203M
$2.62M 0.41%
+5,500
New +$1.73M
BX icon
28
Blackstone
BX
$107B
$2.24M 0.35%
+40,000
New +$2.08M
TRAK icon
29
ReposiTrak
TRAK
$151M
$2.21M 0.35%
+436,445
New +$2.24M
CDNA icon
30
CareDx
CDNA
$2.58B
$2.16M 0.34%
+100,000
New +$2.29M
LBTYK icon
31
Liberty Global Class C
LBTYK
$3.56B
$1.52M 0.24%
+69,618
New +$1.57M
MTB icon
32
M&T Bank
MTB
$34.3B
$1.19M 0.19%
+7,032
New +$1.14M
RTX icon
33
RTX Corp
RTX
$285B
$899K 0.14%
+9,534
New +$865K
BATRK icon
34
Atlanta Braves Holdings Series B
BATRK
$3.24B
$612K 0.1%
+20,717
New +$589K
LBTYA icon
35
Liberty Global Class A
LBTYA
$3.64B
$523K 0.08%
+22,989
New +$542K
INFI
36
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$480K 0.08%
+500,000
New +$549K
XFOR icon
37
X4 Pharmaceuticals
XFOR
$401M
$382K 0.06%
+1,191
New +$427K
LHX icon
38
L3Harris
LHX
$48.9B
$317K 0.05%
+1,600
New +$321K
BATRA icon
39
Atlanta Braves Holdings Series A
BATRA
$3.58B
$307K 0.05%
+10,356
New +$295K
VYGR icon
40
Voyager Therapeutics
VYGR
$218M
$293K 0.05%
+21,029
New +$306K
LILAK icon
41
Liberty Latin America Class C
LILAK
$1.66B
$237K 0.04%
+14,212
New +$220K
LGF.B
42
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$163K 0.03%
+16,413
New +$142K
PHYS icon
43
Sprott Physical Gold
PHYS
$16B
$153K 0.02%
+12,540
New +$149K
VIRX
44
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$99K 0.02%
+8,414
New +$141K
1
2

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return

Bleichroeder LP's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Bleichroeder LP, which disclosed 44 positions worth $632M. Its ten largest holdings account for 78% of the portfolio.

Its largest position is SPDR Gold Trust: 475,000 shares worth $67.9M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, followed by Energy and Industrials.

  • Bleichroeder LP's largest Q4 2019 buy was SPDR Gold Trust: 475,000 shares worth $67.9M.
  • Bleichroeder LP's ten largest holdings make up 78% of its $632M portfolio in Q4 2019.
  • Bleichroeder LP disclosed 44 positions in Q4 2019, its first 13F filing on record.

Based on Bleichroeder LP's 13F filing for Q4 2019, filed 14 Feb 2020.